Bide Pharmatech Co

Bide Pharmatech Co Inventory

The Inventory of Bide Pharmatech Co (688073.SS) as of Oct 27, 2026 is 962.01 M CNY. In the previous year, Inventory was 760.22 M CNY — a change of 26.54% (higher).

Inventory

962.01 MCNY

YoY

26.54%

Last updated:

Inventory of Bide Pharmatech Co is 2025 962.01 M CNY. Inventory of Bide Pharmatech Co was 2024 760.22 M CNY. It decreases by 26.54% higher compared to the previous year.

The Bide Pharmatech Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2020
218.84 M CNY
Jan 1, 2021
476.55 M CNY
Jan 1, 2022
521.86 M CNY
Jan 1, 2023
699.43 M CNY
Jan 1, 2024
760.22 M CNY
Jan 1, 2025
962.01 M CNY
The Bide Pharmatech Co Inventory history
YEARInventoryYoY
962.01 MCNY+26.54%
760.22 MCNY+8.69%
699.43 MCNY+34.03%
521.86 MCNY+9.51%
476.55 MCNY+117.76%
218.84 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co., Ltd. generates revenue through the research, development, design, production, and sales of pharmaceutical molecular building blocks and scientific reagents. The company's primary products serve drug target discovery, seed compound screening, lead compound discovery, synthesis, and optimization processes. Key markets include Asia Pacific, India, Europe, and the United States, where the firm's offerings are utilized by pharmaceutical companies and research institutions. The business model relies on direct sales of its specialized chemical products to these industry segments. The firm's main focus is on developing molecular building blocks for drug development, with products specifically designed for early-stage pharmaceutical research. These building blocks are essential for creating and refining potential drug candidates. The company's operations span multiple global regions, targeting pharmaceutical manufacturers and academic research organizations that require high-quality chemical compounds for their development pipelines. Bide Pharmatech's revenue streams are derived from the sale of its proprietary molecular building blocks and reagents, which are integral to pharmaceutical R&D processes. The company serves clients in the pharmaceutical sector across Asia Pacific, India, Europe, and the United States, delivering products that support critical stages of drug discovery and development. Bide Pharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bide Pharmatech Co stock

Inventory of Bide Pharmatech Co is 962.01 M CNY in 2025.

Inventory of Bide Pharmatech Co changed from 760.22 M CNY to 962.01 M CNY, representing a 26.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Bide Pharmatech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bide Pharmatech Co

All Key Metrics — Bide Pharmatech Co